689 related articles for article (PubMed ID: 9973088)
1. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
2. [Effect of blood flow inhibition in tumors on the effectiveness of hyperglycemia and hyperthermia when used following radiation].
Kozin SV; Sevast'ianov AI
Med Radiol (Mosk); 1987 Jan; 32(1):60-2. PubMed ID: 3807705
[TBL] [Abstract][Full Text] [Related]
3. [Hyperglycemia as a means of increasing the efficacy of hyperthermia in radiotherapy of tumors].
Kozin SV; Voloshina EA; Vinskaia NP; Zolotov VA; Chernikov VI
Med Radiol (Mosk); 1990 Mar; 35(3):3-6. PubMed ID: 2319921
[TBL] [Abstract][Full Text] [Related]
4. [Hydralazine-induced enhancement of hyperthermia treatment in vivo].
Oshima T; Akagi K; Hasegawa T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1582-8. PubMed ID: 1465339
[TBL] [Abstract][Full Text] [Related]
5. Modification of radio-thermo-chemotherapy by AK-2123 and hydralazine in tumor bearing mice.
Kunugita N; Mei N; Norimura T; Kagiya TV
Indian J Exp Biol; 1996 Sep; 34(9):838-41. PubMed ID: 9014514
[TBL] [Abstract][Full Text] [Related]
6. [Polyradiomodification. Optimization of the combined use of hyperglycemia and local hyperthermia in tumor irradiation].
Kozin SV; Voloshina EA; Vinskaia NP; Iarmonenko SP
Med Radiol (Mosk); 1989 Feb; 34(2):67-72. PubMed ID: 2918833
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
Kalmus J; Okunieff P; Vaupel P
Cancer Res; 1990 Jan; 50(1):15-9. PubMed ID: 2293549
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative assessment of morphologic changes in tumors during combined use of irradiation, induced hyperglycemia and local hyperthermia].
Furmanchuk AV; Kozin SV; Strunina IV
Med Radiol (Mosk); 1991; 36(10):24-8. PubMed ID: 1943547
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
10. [Study of anti-tumor effects of hyperthermia combined with hydralazine on experimental tumor].
Aoki Y; Akagi K; Kitada N; Tanaka Y; Fritz-Zieroth B
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):987-92. PubMed ID: 8570396
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonic hyperthermia during radiotherapy of experimental tumors].
Gerchikov AN; Solontsova LV; Kozin SV; Zolotov VA; Gavrilov LR
Med Radiol (Mosk); 1990 Aug; 35(8):13-7. PubMed ID: 2388537
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effect of irradiation followed by hyperglycemia and hyperthermia: the dependence on tumour size and blood flow.
Kozin SV; Zaitsev AV; Yarmonenko SP
Int J Hyperthermia; 1996; 12(1):147-56. PubMed ID: 8676002
[TBL] [Abstract][Full Text] [Related]
13. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
14. [Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia].
Ohshima T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):960-9. PubMed ID: 8371944
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
Horsman MR; Christensen KL; Overgaard J
Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
[TBL] [Abstract][Full Text] [Related]
16. [Polyradiomodification. The efficacy of the postradiation use of hyperglycemia and hyperthermia in treating tumors of different sizes].
Kozin SV; Voloshina EA; Vinskaia NP; Zaĭtsev AV
Med Radiol (Mosk); 1990 Jul; 35(7):52-4. PubMed ID: 2374488
[TBL] [Abstract][Full Text] [Related]
17. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
[TBL] [Abstract][Full Text] [Related]
19. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response.
Leunig M; Goetz AE; Dellian M; Zetterer G; Gamarra F; Jain RK; Messmer K
Cancer Res; 1992 Jan; 52(2):487-90. PubMed ID: 1728421
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
